Research

As director of the Center on Aging and Behavioral Research, Dr. Sara Czaja and her team are developing and testing innovative strategies and interventions that strive to keep older adults independent and engaged, socially, intellectually and even professionally.

A protein linked to both Alzheimer’s disease and a form of dementia increases the risk of cognitive impairment by reducing the number and responsiveness of blood vessels in the organ.

With a $7.5 million gift from the Friedman Family Foundation endowed by Stephen and Vice Chair Overseer Barbara Friedman, Weill Cornell Medicine has established an innovative cross-campus center dedicated to improving human health through research in the complex relationship between nutrition, inflammation and the development of disease.

Magnetic resonance imaging (MRI) may not be the best diagnostic choice universally for all men suspected of having prostate cancer, according to researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Dr. Mary Charlson and investigators from the Clinical Directors Network have been awarded a $7.6 million, five-year contract from the Patient-Centered Outcomes Research Institute to study how health coaches may affect the health and wellness of patients with multiple chronic diseases.

Three distinguished Weill Cornell Medicine physician-scientists, Dr. Daniel Fitzgerald, Dr. Francis Lee and Dr. Virginia Pascual, have been inducted into the Association of American Physicians (AAP).

Levels of air pollution defined as “good” by the Environmental Protection Agency (EPA) may still harm the lungs of cigarette smokers, according to a new study conducted by Weill Cornell Medicine and NewYork-Presbyterian investigators.

By sabotaging one of the tuberculosis bacterium’s defenses against antibiotics, Weill Cornell Medicine investigators may have found a way to accelerate treatment for the disease and possibly overcome growing resistance to existing therapies.  

Sensory stimulation during a critical period soon after birth is essential for establishing networks in the brain...

Dr. Kaushal is one of 78 women chosen by Crain’s New York Business to honor female professionals working in healthcare whose contributions have significantly influenced New York City. http://www.crainsnewyork.com/assets/pdf/CN11652782.PDFhttp://hpr.weill.cornell.edu/https://www.joinallofus.org/en/nyc

A new method for testing urinary tract infections yields more information than what conventional methods can offer, according to new research from investigators at Weill Cornell Medicine, Cornell’s Meinig School of Biomedical Engineering and NewYork-Presbyterian.

Conventional wisdom suggests that a high level of the protein prostate specific antigen (PSA) in men with prostate cancer means a poor prognosis. However, this may not always be the case in men with a particular subtype of prostate cancer, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian researchers.

A minimally invasive procedure to replace the heart’s aortic valve has recently increased in popularity despite a lack of research on the new valves’ long-term durability, according to a new study from Weill Cornell Medicine.

New molecules engineered by Weill Cornell Medicine researchers can enable rapid, direct “editing” of genes in a wide range of cell types, creating an array of research and therapeutic possibilities.

Dr. Shuibing Chen, an associate professor of chemical biology in surgery and in biochemistry at Weill Cornell Medicine, has received the ISSCR Dr. Susan Lim Award for Outstanding Young Investigator from the International Society for Stem Cell Research (ISSCR).

Treating early-stage lung cancers with drugs that unleash the immune system’s ability to attack malignant cells may hinder tumor growth and improve overall survival, according to new research by Weill Cornell Medicine and NewYork-Presbyterian investigators. 

Dr. Francis Lee, a leading physician-scientist whose research focuses on anxiety disorders, has been named chairman of the Department of Psychiatry at Weill Cornell Medicine and psychiatrist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.

Gene mutations detected in blood may predict risk of one of the most common forms of adult leukemia a decade before patients are diagnosed with the disease, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian investigators.

An existing malaria drug could improve the effectiveness of a new class of cancer therapies, called glutaminase inhibitors, if used in combination, researchers at Weill Cornell Medicine-Qatar (WCM-Q) discovered in a new study.

A very low carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, according to a study in mice by investigators at Weill Cornell Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian.